We here report serological, MRI, and CSF features of 22 patients affected with IDD who resulted seropositive for MOG-Ab and compare them with a group of seronegative cases, with the aim of investigating the diagnostic and prognostic utility of this immunological marker. This evidence concerns the gene MOG and intervertebral disk degenerative disorder.